223 related articles for article (PubMed ID: 26668013)
1. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.
Feodoroff M; Harjutsalo V; Forsblom C; Thorn L; Wadén J; Tolonen N; Lithovius R; Groop PH
Acta Diabetol; 2016 Aug; 53(4):525-33. PubMed ID: 26668013
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes.
Wadén JM; Dahlström EH; Elonen N; Thorn LM; Wadén J; Sandholm N; Forsblom C; Groop PH;
Diabetologia; 2019 Jul; 62(7):1268-1274. PubMed ID: 31127314
[TBL] [Abstract][Full Text] [Related]
5. Depression Is Associated With Progression of Diabetic Nephropathy in Type 1 Diabetes.
Ahola AJ; Harjutsalo V; Forsblom C; Pouwer F; Groop PH;
Diabetes Care; 2021 Jan; 44(1):174-180. PubMed ID: 33177173
[TBL] [Abstract][Full Text] [Related]
6. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.
Phisitkul K; Hegazy K; Chuahirun T; Hudson C; Simoni J; Rajab H; Wesson DE
Am J Med Sci; 2008 Apr; 335(4):284-91. PubMed ID: 18414067
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
Overgaard AJ; McGuire JN; Hovind P; Parving HH; Rossing P; Pociot F
J Diabetes Complications; 2013; 27(1):59-63. PubMed ID: 22885250
[TBL] [Abstract][Full Text] [Related]
8. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
[TBL] [Abstract][Full Text] [Related]
9. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
Harjutsalo V; Thomas MC; Forsblom C; Groop PH;
Diabetes Obes Metab; 2018 Dec; 20(12):2759-2767. PubMed ID: 29962015
[TBL] [Abstract][Full Text] [Related]
10. Smoking is associated with progression of diabetic nephropathy.
Sawicki PT; Didjurgeit U; Mühlhauser I; Bender R; Heinemann L; Berger M
Diabetes Care; 1994 Feb; 17(2):126-31. PubMed ID: 8137682
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
Rossing P; Hougaard P; Parving HH
Diabetes Care; 2002 May; 25(5):859-64. PubMed ID: 11978681
[TBL] [Abstract][Full Text] [Related]
13. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
[TBL] [Abstract][Full Text] [Related]
14. Smoking and progression of diabetic nephropathy in type 1 diabetes.
Hovind P; Rossing P; Tarnow L; Parving HH
Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
[TBL] [Abstract][Full Text] [Related]
15. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
Oellgaard J; Gæde P; Rossing P; Persson F; Parving HH; Pedersen O
Kidney Int; 2017 Apr; 91(4):982-988. PubMed ID: 28187983
[TBL] [Abstract][Full Text] [Related]
16. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
17. Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset.
Costacou T; Orchard TJ
Diabetes Care; 2018 Mar; 41(3):426-433. PubMed ID: 28931542
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.
Raile K; Galler A; Hofer S; Herbst A; Dunstheimer D; Busch P; Holl RW
Diabetes Care; 2007 Oct; 30(10):2523-8. PubMed ID: 17630266
[TBL] [Abstract][Full Text] [Related]
19. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
20. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients.
Nielsen SE; Sugaya T; Hovind P; Baba T; Parving HH; Rossing P
Diabetes Care; 2010 Jun; 33(6):1320-4. PubMed ID: 20185732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
